Victory Capital Management Inc. increased its stake in Equifax, Inc. (NYSE:EFX - Free Report) by 4.3% during the first quarter, according to its most recent filing with the Securities & Exchange Commission. The fund owned 47,178 shares of the credit services provider's stock after acquiring an additional 1,964 shares during the quarter. Victory Capital Management Inc.'s holdings in Equifax were worth $11,491,000 at the end of the most recent quarter.
A number of other hedge funds have also modified their holdings of EFX. True Wealth Design LLC grew its holdings in shares of Equifax by 1,920.0% in the 4th quarter. True Wealth Design LLC now owns 101 shares of the credit services provider's stock worth $26,000 after acquiring an additional 96 shares during the last quarter. Ameriflex Group Inc. acquired a new position in shares of Equifax in the 4th quarter worth $28,000. Colonial Trust Co SC grew its holdings in shares of Equifax by 505.0% in the 4th quarter. Colonial Trust Co SC now owns 121 shares of the credit services provider's stock worth $31,000 after acquiring an additional 101 shares during the last quarter. City Holding Co. purchased a new position in shares of Equifax during the first quarter valued at $34,000. Finally, ST Germain D J Co. Inc. purchased a new position in shares of Equifax during the first quarter valued at $38,000. 96.20% of the stock is currently owned by institutional investors and hedge funds.
Insider Transactions at Equifax
In other news, CEO Mark W. Begor sold 22,160 shares of Equifax stock in a transaction dated Monday, April 28th. The stock was sold at an average price of $256.61, for a total value of $5,686,477.60. Following the transaction, the chief executive officer directly owned 142,395 shares in the company, valued at approximately $36,539,980.95. The trade was a 13.47% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which is accessible through this hyperlink. Also, EVP John W. Gamble, Jr. sold 2,000 shares of the business's stock in a transaction dated Tuesday, May 6th. The shares were sold at an average price of $259.10, for a total value of $518,200.00. Following the transaction, the executive vice president owned 65,176 shares in the company, valued at $16,887,101.60. This represents a 2.98% decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders own 1.40% of the company's stock.
Equifax Stock Up 0.1%
Shares of NYSE:EFX traded up $0.33 on Friday, reaching $246.31. The company had a trading volume of 968,798 shares, compared to its average volume of 1,080,253. Equifax, Inc. has a twelve month low of $199.98 and a twelve month high of $309.63. The stock has a 50-day moving average price of $261.29 and a 200 day moving average price of $253.12. The stock has a market capitalization of $30.49 billion, a P/E ratio of 48.20, a P/E/G ratio of 2.60 and a beta of 1.60. The company has a quick ratio of 0.85, a current ratio of 0.77 and a debt-to-equity ratio of 0.79.
Equifax (NYSE:EFX - Get Free Report) last announced its quarterly earnings results on Tuesday, July 22nd. The credit services provider reported $2.00 earnings per share for the quarter, topping analysts' consensus estimates of $1.92 by $0.08. Equifax had a return on equity of 18.89% and a net margin of 10.95%. The company had revenue of $1.54 billion during the quarter, compared to analysts' expectations of $1.51 billion. During the same quarter in the previous year, the firm earned $1.82 earnings per share. The business's quarterly revenue was up 7.4% compared to the same quarter last year. On average, equities analysts expect that Equifax, Inc. will post 7.58 EPS for the current year.
Analyst Upgrades and Downgrades
A number of research analysts have recently weighed in on the company. Oppenheimer lowered their price target on Equifax from $296.00 to $279.00 and set an "outperform" rating on the stock in a report on Wednesday. JPMorgan Chase & Co. lowered their price target on Equifax from $277.00 to $272.00 and set an "overweight" rating on the stock in a report on Wednesday. BMO Capital Markets lowered their price target on Equifax from $280.00 to $260.00 and set a "market perform" rating on the stock in a report on Wednesday. Stifel Nicolaus lifted their price target on Equifax from $277.00 to $295.00 and gave the company a "buy" rating in a report on Wednesday, June 18th. Finally, Citigroup lowered their price target on Equifax from $294.00 to $290.00 and set a "buy" rating on the stock in a report on Wednesday. Seven equities research analysts have rated the stock with a hold rating, twelve have issued a buy rating and one has assigned a strong buy rating to the company's stock. Based on data from MarketBeat, the stock has an average rating of "Moderate Buy" and a consensus price target of $285.00.
Read Our Latest Report on EFX
Equifax Profile
(
Free Report)
Equifax Inc operates as a data, analytics, and technology company. The company operates through three segments: Workforce Solutions, U.S. Information Solutions (USIS), and International. The Workforce Solutions segment offers services that enables customers to verify income, employment, educational history, criminal justice data, healthcare professional licensure, and sanctions of people in the United States; and employer customers with services that assist them in complying with and automating payroll-related and human resource management processes throughout the entire cycle of the employment relationship.
Read More

Before you consider Equifax, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Equifax wasn't on the list.
While Equifax currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Unlock your free copy of MarketBeat's comprehensive guide to pot stock investing and discover which cannabis companies are poised for growth. Plus, you'll get exclusive access to our daily newsletter with expert stock recommendations from Wall Street's top analysts.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.